Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 5813794, 13 pages
http://dx.doi.org/10.1155/2016/5813794
Research Article

Protective Effect of Galectin-1 during Histoplasma capsulatum Infection Is Associated with Prostaglandin E2 and Nitric Oxide Modulation

1Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo (USP), 14040-903 Ribeirão Preto, SP, Brazil
2Departamento de Ciências Biológicas, Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista (UNESP), 14801-902 Araraquara, SP, Brazil
3Departamento de Patologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo (USP), 14049-900 Ribeirão Preto, SP, Brazil
4Department of Surgery, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02115, USA
5Department of Pathology, Emory University School of Medicine, Atlanta, GA 30322, USA

Received 16 April 2016; Revised 27 July 2016; Accepted 1 August 2016

Academic Editor: Marc Pouliot

Copyright © 2016 Lílian Cataldi Rodrigues et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Allendoerfer and G. S. Deepe Jr., “Infection with Histoplasma capsulatum: host-fungus interface,” Revista Iberoamericana de Micologia, vol. 15, no. 4, pp. 256–260, 1998. View at Google Scholar · View at Scopus
  2. S. Antinori, “Histoplasma capsulatum: more widespread than previously thought,” The American Journal of Tropical Medicine and Hygiene, vol. 90, no. 6, pp. 982–983, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. G. D. Brown, D. W. Denning, N. A. R. Gow, S. M. Levitz, M. G. Netea, and T. C. White, “Hidden killers: human fungal infections,” Science Translational Medicine, vol. 4, no. 165, Article ID 165rv13, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. A. A. Adenis, C. Aznar, and P. Couppié, “Histoplasmosis in HIV-infected patients: a review of new developments and remaining gaps,” Current Tropical Medicine Reports, vol. 1, pp. 119–128, 2014. View at Publisher · View at Google Scholar
  5. G. S. Deepe Jr., R. S. Gibbons, and A. G. Smulian, “Histoplasma capsulatum manifests preferential invasion of phagocytic subpopulations in murine lungs,” Journal of Leukocyte Biology, vol. 84, no. 3, pp. 669–678, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. D. N. Kroetz and G. S. Deepe, “The role of cytokines and chemokines in Histoplasma capsulatum infection,” Cytokine, vol. 58, no. 1, pp. 112–117, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Allendoerfer, G. P. Boivin, and G. S. Deepe Jr., “Modulation of immune responses in murine pulmonary histoplasmosis,” Journal of Infectious Diseases, vol. 175, no. 4, pp. 905–914, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. P. A. T. Pereira, B. C. Trindade, A. Secatto et al., “Celecoxib improves host defense through prostaglandin inhibition during histoplasma capsulatum infection,” Mediators of Inflammation, vol. 2013, Article ID 950981, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. A. I. Medeiros, A. Sá-Nunes, E. G. Soares, C. M. Peres, C. L. Silva, and L. H. Faccioli, “Blockade of endogenous leukotrienes exacerbates pulmonary histoplasmosis,” Infection and Immunity, vol. 72, no. 3, pp. 1637–1644, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. T. E. Lane, B. A. Wu-Hsieh, and D. H. Howard, “Antihistoplasma effect of activated mouse splenic macrophages involves production of reactive nitrogen intermediates,” Infection and Immunity, vol. 62, no. 5, pp. 1940–1945, 1994. View at Google Scholar · View at Scopus
  11. T. E. Lane, G. C. Otero, B. A. Wu-Hsieh, and D. H. Howard, “Expression of inducible nitric oxide synthase by stimulated macrophages correlates with their antihistoplasma activity,” Infection and Immunity, vol. 62, no. 4, pp. 1478–1479, 1994. View at Google Scholar · View at Scopus
  12. B. A. Wu-Hsieh, W. Chen, and H.-J. Lee, “Nitric oxide synthase expression in macrophages of Histoplasma capsulatum-infected mice is associated with splenocyte apoptosis and unresponsiveness,” Infection and Immunity, vol. 66, no. 11, pp. 5520–5526, 1998. View at Google Scholar · View at Scopus
  13. S.-Y. Wu, J.-S. Yu, F.-T. Liu, S.-C. Miaw, and B. A. Wu-Hsieh, “Galectin-3 negatively regulates dendritic cell production of IL-23/IL-17-axis cytokines in infection by Histoplasma capsulatum,” The Journal of Immunology, vol. 190, no. 7, pp. 3427–3437, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. G. A. Rabinovich and A. Gruppi, “Galectins as immunoregulators during infectious processes: from microbial invasion to the resolution of the disease,” Parasite Immunology, vol. 27, no. 4, pp. 103–114, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. D. J. Laderach, D. Compagno, M. A. Toscano et al., “Dissecting the signal transduction pathways triggered by galectin-glycan interactions in physiological and pathological settings,” IUBMB Life, vol. 62, no. 1, pp. 1–13, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. F.-T. Liu, R.-Y. Yang, and D. K. Hsu, “Galectins in acute and chronic inflammation,” Annals of the New York Academy of Sciences, vol. 1253, no. 1, pp. 80–91, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Thiemann and L. G. Baum, “Galectins and immune responses—just how do they do those things they do?” Annual Review of Immunology, vol. 34, no. 1, pp. 243–264, 2016. View at Publisher · View at Google Scholar
  18. K. Wdowiak, W. Spychalowicz, M. Fajkis, and J. Wojnar, “Galectins in hematological malignancies-role, functions and potential therapeutic targets,” Postępy Higieny i Medycyny Doświadczalnej, vol. 70, pp. 95–103, 2016. View at Google Scholar
  19. E. Zúñiga, A. Gruppi, J. Hirabayashi, K. I. Kasai, and G. A. Rabinovich, “Regulated expression and effect of galectin-1 on Trypanosoma cruzi-infected macrophages: modulation of microbicidal activity and survival,” Infection and Immunity, vol. 69, no. 11, pp. 6804–6812, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Ouellet, S. Mercier, I. Pelletier et al., “Galectin-1 acts as a soluble host factor that promotes HIV-1 infectivity through stabilization of virus attachment to host cells,” The Journal of Immunology, vol. 174, no. 7, pp. 4120–4126, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. K. A. Toledo, M. L. Fermino, C. Del Cistia Andrade et al., “Galectin-1 exerts inhibitory effects during DENV-1 infection,” PLoS ONE, vol. 9, no. 11, article e112474, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. S. R. Stowell, Y. Qian, S. Karmakar et al., “Differential roles of galectin-1 and galectin-3 in regulating leukocyte viability and cytokine secretion,” Journal of Immunology, vol. 180, no. 5, pp. 3091–3102, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. S. G. Correa, C. E. Sotomayor, M. P. Aoki, C. A. Maldonado, and G. A. Rabinovich, “Opposite effects of galectin-1 on alternative metabolic pathways of L-arginine in resident, inflammatory, and activated macrophages,” Glycobiology, vol. 13, no. 2, pp. 119–128, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. L. V. Norling, A. L. F. Sampaio, D. Cooper, and M. Perretti, “Inhibitory control of endothelial galectin-1 on in vitro and in vivo lymphocyte trafficking,” The FASEB Journal, vol. 22, no. 3, pp. 682–690, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. C. V. Poncini, J. M. Ilarregui, E. I. Batalla et al., “Trypanosoma cruzi infection imparts a regulatory program in dendritic cells and T cells via galectin-1-dependent mechanisms,” Journal of Immunology, vol. 195, no. 7, pp. 3311–3324, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Dias-Baruffi, H. Zhu, M. Cho, S. Karmakar, R. P. McEver, and R. D. Cummings, “Dimeric galectin-1 induces surface exposure of phosphatidylserine and phagocytic recognition of leukocytes without inducing apoptosis,” Journal of Biological Chemistry, vol. 278, no. 42, pp. 41282–41293, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. G. A. Rabinovich, C. E. Sotomayor, C. M. Riera, I. Bianco, and S. G. Correa, “Evidence of a role for galectin-1 in acute inflammation,” European Journal of Immunology, vol. 30, no. 5, pp. 1331–1339, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. F.-T. Liu, R. J. Patterson, and J. L. Wang, “Intracellular functions of galectins,” Biochimica et Biophysica Acta (BBA)—General Subjects, vol. 1572, no. 2-3, pp. 263–273, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. M. C. Vladoiu, M. Labrie, and Y. St-Pierre, “Intracellular galectins in cancer cells: potential new targets for therapy (review),” International Journal of Oncology, vol. 44, no. 4, pp. 1001–1014, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Kurita, E. Brummer, S. Yoshida, K. Nishimura, and M. Miyaji, “Antifungal activity of murine polymorphonuclear neutrophils against histoplasma capsulatum,” Medical Mycology, vol. 29, no. 3, pp. 133–143, 1991. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Allendoerfer and G. S. Deepe Jr., “Intrapulmonary response to Histoplasma capsulatum in gamma interferon knockout mice,” Infection and Immunity, vol. 65, no. 7, pp. 2564–2569, 1997. View at Google Scholar · View at Scopus
  32. G. S. Deepe Jr., R. Gibbons, and E. Woodward, “Neutralization of endogenous granulocyte-macrophage colony-stimulating factor subverts the protective immune response to Histoplasma capsulatum,” The Journal of Immunology, vol. 163, no. 9, pp. 4985–4993, 1999. View at Google Scholar · View at Scopus
  33. G. S. Deepe Jr. and R. S. Gibbons, “Interleukins 17 and 23 influence the host response to Histoplasma capsulatum,” Journal of Infectious Diseases, vol. 200, no. 1, pp. 142–151, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Zhou, M. C. Sieve, J. Bennett et al., “IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-γ,” Journal of Immunology, vol. 155, no. 2, pp. 785–795, 1995. View at Google Scholar · View at Scopus
  35. J. E. Wolf, S. E. Massof, and S. P. Peters, “Alterations in murine macrophage arachidonic acid metabolism following ingestion of nonviable Histoplasma capsulatum,” Infection and Immunity, vol. 60, no. 7, pp. 2559–2564, 1992. View at Google Scholar · View at Scopus
  36. S. R. Stowell, C. M. Arthur, M. Dias-Baruffi et al., “Innate immune lectins kill bacteria expressing blood group antigen,” Nature Medicine, vol. 16, no. 3, pp. 295–301, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. J. P. Cerliani, S. R. Stowell, I. D. Mascanfroni, C. M. Arthur, R. D. Cummings, and G. A. Rabinovich, “Expanding the universe of cytokines and pattern recognition receptors: galectins and glycans in innate immunity,” Journal of Clinical Immunology, vol. 31, no. 1, pp. 10–21, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Sato, C. St-Pierre, P. Bhaumik, and J. Nieminen, “Galectins in innate immunity: dual functions of host soluble β-galactoside-binding lectins as damage-associated molecular patterns (DAMPs) and as receptors for pathogen-associated molecular patterns (PAMPs),” Immunological Reviews, vol. 230, no. 1, pp. 172–187, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. J. R. Linden, M. E. De Paepe, S. S. Laforce-Nesbitt, and J. M. Bliss, “Galectin-3 plays an important role in protection against disseminated candidiasis,” Medical Mycology, vol. 51, no. 6, pp. 641–651, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. R. N. Fichorova, H. S. Yamamoto, T. Fashemi et al., “Trichomonas vaginalis lipophosphoglycan exploits binding to galectin-1 and -3 to modulate epithelial immunity,” Journal of Biological Chemistry, vol. 291, no. 2, pp. 998–1013, 2016. View at Publisher · View at Google Scholar · View at Scopus
  41. C. I. Muglia, R. P. Gobbi, P. Smaldini et al., “Inflammation controls sensitivity of human and mouse intestinal epithelial cells to galectin-1,” Journal of Cellular Physiology, vol. 231, no. 7, pp. 1575–1585, 2016. View at Publisher · View at Google Scholar · View at Scopus
  42. I. Camby, M. Le Mercier, F. Lefranc, and R. Kiss, “Galectin-1: a small protein with major functions,” Glycobiology, vol. 16, no. 11, pp. 137R–157R, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. G. R. Vasta, “Roles of galectins in infection,” Nature Reviews Microbiology, vol. 7, no. 6, pp. 424–438, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. L. Kohatsu, D. K. Hsu, A. G. Jegalian, F.-T. Liu, and L. G. Baum, “Galectin-3 induces death of Candida species expressing specific β-1,2-linked mannans,” Journal of Immunology, vol. 177, no. 7, pp. 4718–4726, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. A. F. Benatar, G. A. García, J. Bua et al., “Galectin-1 prevents infection and damage induced by Trypanosoma cruzi on cardiac cells,” PLOS Neglected Tropical Diseases, vol. 9, no. 10, Article ID e0004148, 2015. View at Publisher · View at Google Scholar
  46. S. R. Stowell, C. M. Arthur, R. McBride et al., “Microbial glycan microarrays define key features of host-microbial interactions,” Nature Chemical Biology, vol. 10, no. 6, pp. 470–476, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. C. D. Gil, C. E. Gullo, and S. M. Oliani, “Effect of exogenous galectin-1 on leukocyte migration: modulation of cytokine levels and adhesion molecules,” International Journal of Clinical and Experimental Pathology, vol. 4, no. 1, pp. 74–84, 2010. View at Google Scholar · View at Scopus
  48. E. Kolaczkowska and P. Kubes, “Neutrophil recruitment and function in health and inflammation,” Nature Reviews Immunology, vol. 13, no. 3, pp. 159–175, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. S. L. Newman, L. Gootee, and J. E. Gabay, “Human neutrophil-mediated fungistasis against Histoplasma capsulatum: localization of fungistatic activity to the azurophil granules,” The Journal of Clinical Investigation, vol. 92, no. 2, pp. 624–631, 1993. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Sá-Nunes, A. I. Medeiros, C. A. Sorgi et al., “Gr-1+ cells play an essential role in an experimental model of disseminated histoplasmosis,” Microbes and Infection, vol. 9, no. 12-13, pp. 1393–1401, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. D. Cooper, L. V. Norling, and M. Perretti, “Novel insights into the inhibitory effects of Galectin-1 on neutrophil recruitment under flow,” Journal of Leukocyte Biology, vol. 83, no. 6, pp. 1459–1466, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. N. Schmitz, M. Kurrer, M. F. Bachmann, and M. Kopf, “Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection,” Journal of Virology, vol. 79, no. 10, pp. 6441–6448, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. L. H. Faccioli, G. E. P. Souza, F. Q. Cunha, S. Poole, and S. H. Ferreira, “Recombinant interleukin-1 and tumor necrosis factor induce neutrophil migration ‘in vivo’ by indirect mechanisms,” Agents and Actions, vol. 30, no. 3-4, pp. 344–349, 1990. View at Publisher · View at Google Scholar · View at Scopus
  54. L. Romani, A. Mencacci, E. Cenci et al., “Neutrophil production of IL-12 and IL-10 in candidiasis and efficacy of IL-12 therapy in neutropenic mice,” The Journal of Immunology, vol. 158, no. 11, pp. 5349–5356, 1997. View at Google Scholar · View at Scopus
  55. J. Zhong, W. Huang, Q. Deng et al., “Inhibition of TREM-1 and Dectin-1 alleviates the severity of fungal keratitis by modulating innate immune responses,” PLoS ONE, vol. 11, no. 3, Article ID e0150114, 2016. View at Publisher · View at Google Scholar
  56. R. Allendoerfer and G. S. Deepe Jr., “Regulation of infection with Histoplasma capsulatum by TNFR1 and -2,” The Journal of Immunology, vol. 165, no. 5, pp. 2657–2664, 2000. View at Publisher · View at Google Scholar · View at Scopus
  57. G. S. Deepe Jr., “Immune response to early and late Histoplasma capsulatum infections,” Current Opinion in Microbiology, vol. 3, no. 4, pp. 359–362, 2000. View at Publisher · View at Google Scholar · View at Scopus
  58. N. K. Rajasagi, A. Suryawanshi, S. Sehrawat et al., “Galectin-1 reduces the severity of herpes simplex virus-induced ocular immunopathological lesions,” Journal of Immunology, vol. 188, no. 9, pp. 4631–4643, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. M. A. Toscano, G. A. Bianco, J. M. Ilarregui et al., “Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death,” Nature Immunology, vol. 8, no. 8, pp. 825–834, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. D. M. Floss, J. Schröder, M. Franke, and J. Scheller, “Insights into IL-23 biology: from structure to function,” Cytokine & Growth Factor Reviews, vol. 26, no. 5, pp. 569–578, 2015. View at Publisher · View at Google Scholar · View at Scopus
  61. J. Wang, J. Xia, F. Zhang et al., “Galectin-1-secreting neural stem cells elicit long-term neuroprotection against ischemic brain injury,” Scientific Reports, vol. 5, article 9621, 2015. View at Publisher · View at Google Scholar · View at Scopus
  62. D. Pineda, C. Ampurdanés, M. G. Medina et al., “Tissue plasminogen activator induces microglial inflammation via a noncatalytic molecular mechanism involving activation of mitogen-activated protein kinases and Akt signaling pathways and AnnexinA2 and Galectin-1 receptors,” Glia, vol. 60, no. 4, pp. 526–540, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. S. L. Hempel, M. M. Monick, and G. W. Hunninghake, “Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes,” The Journal of Clinical Investigation, vol. 93, no. 1, pp. 391–396, 1994. View at Publisher · View at Google Scholar · View at Scopus
  64. D. M. Aronoff, C. Lewis, C. H. Serezani et al., “E-prostanoid 3 receptor deletion improves pulmonary host defense and protects mice from death in severe Streptococcus pneumoniae infection,” Journal of Immunology, vol. 183, no. 4, pp. 2642–2649, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. C. H. Serezani, J. Chung, M. N. Ballinger, B. B. Moore, D. M. Aronoff, and M. Peters-Golden, “Prostaglandin E2 suppresses bacterial killing in alveolar macrophages by inhibiting NADPH oxidase,” American Journal of Respiratory Cell and Molecular Biology, vol. 37, no. 5, pp. 562–570, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. R. Domingo-Gonzalez, S. Katz, C. H. Serezani, T. A. Moore, A. M. LeVine, and B. B. Moore, “Prostaglandin E2-induced changes in alveolar macrophage scavenger receptor profiles differentially alter phagocytosis of Pseudomonas aeruginosa and Staphylococcus aureus post-bone marrow transplant,” Journal of Immunology, vol. 190, no. 11, pp. 5809–5817, 2013. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Rodríguez, E. Domingo, C. Municio et al., “Polarization of the innate immune response by prostaglandin E2: a puzzle of receptors and signals,” Molecular Pharmacology, vol. 85, no. 1, pp. 187–197, 2014. View at Publisher · View at Google Scholar · View at Scopus
  68. L. Santucci, S. Fiorucci, N. Rubinstein et al., “Galectin-1 suppresses experimental colitis in mice,” Gastroenterology, vol. 124, no. 5, pp. 1381–1394, 2003. View at Publisher · View at Google Scholar · View at Scopus
  69. J. M. Ilarregui, D. O. Croci, G. A. Bianco et al., “Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10,” Nature Immunology, vol. 10, no. 9, pp. 981–991, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. P.-L. Kuo, J.-Y. Hung, S.-K. Huang et al., “Lung cancer-derived galectin-1 mediates dendritic cell anergy through inhibitor of DNA binding 3/IL-10 signaling pathway,” Journal of Immunology, vol. 186, no. 3, pp. 1521–1530, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. J. A. Fulcher, S. T. Hashimi, E. L. Levroney et al., “Galectin-1-matured human monocyte-derived dendritic cells have enhanced migration through extracellular matrix,” The Journal of Immunology, vol. 177, no. 1, pp. 216–226, 2006. View at Publisher · View at Google Scholar · View at Scopus
  72. A. Medeiros, C. Peres-Buzalaf, F. Fortino Verdan, and C. H. Serezani, “Prostaglandin E2 and the suppression of phagocyte innate immune responses in different organs,” Mediators of Inflammation, vol. 2012, Article ID 327568, 13 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  73. C. H. Serezani, J. H. Perrela, M. Russo, M. Peters-Golden, and S. Jancar, “Leukotrienes are essential for the control of Leishmania amazonensis infection and contribute to strain variation in susceptibility,” Journal of Immunology, vol. 177, no. 5, pp. 3201–3208, 2006. View at Publisher · View at Google Scholar · View at Scopus
  74. F. Rezaie, M. Salimi, M. H. Ghahremani, and B. Vaziri, “Potential molecular targets in chemopreventative action of celecoxib: a proteomics analysis of J774.A1 macrophage-like cell line,” Molecular BioSystems, vol. 7, no. 4, pp. 1306–1311, 2011. View at Publisher · View at Google Scholar · View at Scopus
  75. J. Hellmann, Y. Tang, M. J. Zhang et al., “Atf3 negatively regulates Ptgs2/Cox2 expression during acute inflammation,” Prostaglandins & Other Lipid Mediators, vol. 116-117, pp. 49–56, 2015. View at Publisher · View at Google Scholar · View at Scopus
  76. S. Hangai, T. Ao, Y. Kimura et al., “PGE2 induced in and released by dying cells functions as an inhibitory DAMP,” Proceedings of the National Academy of Sciences of the United States of America, vol. 113, no. 14, pp. 3844–3849, 2016. View at Publisher · View at Google Scholar
  77. R. Duffin, R. A. O'Connor, S. Crittenden et al., “Prostaglandin E2 constrains systemic inflammation through an innate lymphoid cell-IL-22 axis,” Science, vol. 351, no. 6279, pp. 1333–1338, 2016. View at Publisher · View at Google Scholar
  78. A. Sá-Nunes, A. I. Medeiros, R. Nicolete et al., “Efficacy of cell-free antigens in evaluating cell immunity and inducing protection in a murine model of histoplasmosis,” Microbes and Infection, vol. 7, no. 4, pp. 584–592, 2005. View at Publisher · View at Google Scholar · View at Scopus
  79. A. I. Medeiros, C. L. Silva, A. Malheiro, C. M. L. Maffei, and L. H. Faccioli, “Leukotrienes are involved in leukocyte recruitment induced by live Histoplasma capsulatum or by the β-glucan present in their cell wall,” British Journal of Pharmacology, vol. 128, no. 7, pp. 1529–1537, 1999. View at Publisher · View at Google Scholar · View at Scopus
  80. B. Corrêa, A. Purchio, C. R. Paula, W. Gambale, and M. A. Shikanai-Yasuda, “Fluorescent method (fluorescein diacetate and ethidium bromide) to study the viability of Cryptococcus neoformans in liquor,” Revista do Instituto de Medicina Tropical de Sao Paulo, vol. 32, no. 1, pp. 46–50, 1990. View at Google Scholar · View at Scopus
  81. M. Cho and R. D. Cummings, “Galectin-1, a β-galactoside-binding lectin in Chinese hamster ovary cells. II. Localization and biosynthesis,” The Journal of Biological Chemistry, vol. 270, no. 10, pp. 5207–5212, 1995. View at Publisher · View at Google Scholar · View at Scopus
  82. P. L. Whitney, J. T. Powell, and G. L. Sanford, “Oxidation and chemical modification of lung β-galactoside-specific lectin,” Biochemical Journal, vol. 238, no. 3, pp. 683–689, 1986. View at Publisher · View at Google Scholar · View at Scopus